Disclosed is a pharmaceutical composition for treating and/or preventing cancer. The pharmaceutical composition comprises, as an active ingredient, an antibody capable of immunologically reacting with CAPRIN-1 protein or a fragment thereof comprising seven or more contiguous amino acid residues or a fragment of the antibody.